Evidence map›Paper›PMID 40267215›Full record

ArticleScience translational medicine2025

A high-resolution screen identifies a preexisting beta-lactam that specifically treats Lyme disease in mice.

Maegan E Gabby, Abey Bandara, L M Outrata, Osamudiamen Ebohon, Saadman S Ahmad, Jules M Dressler, Mecaila E McClune, Rebecca N Trimble, Lainey Mullen, Brandon L Jutras

Abstract read
In one paragraph

Article in Science translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Insights into Lyme arthritis.Nature reviews. Rheumatology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Maegan E GabbyDepartment of Biochemistry, Virginia Tech, Blacksburg, VA 24061, USA.ORCID 0009-0003-4141-4656
Abey BandaraDepartment of Biochemistry, Virginia Tech, Blacksburg, VA 24061, USA.
L M OutrataDepartment of Biochemistry, Virginia Tech, Blacksburg, VA 24061, USA.ORCID 0009-0005-1393-2194
Osamudiamen EbohonDepartment of Biochemistry, Virginia Tech, Blacksburg, VA 24061, USA.ORCID 0000-0003-3547-6933
Saadman S AhmadDepartment of Biochemistry, Virginia Tech, Blacksburg, VA 24061, USA.ORCID 0009-0008-5889-8147
Jules M DresslerDepartment of Biochemistry, Virginia Tech, Blacksburg, VA 24061, USA.ORCID 0000-0001-5460-8968
Mecaila E McCluneDepartment of Biochemistry, Virginia Tech, Blacksburg, VA 24061, USA.ORCID 0000-0002-9071-540X
Rebecca N TrimbleDepartment of Biochemistry, Virginia Tech, Blacksburg, VA 24061, USA.
Lainey MullenDepartment of Biochemistry, Virginia Tech, Blacksburg, VA 24061, USA.
Brandon L JutrasDepartment of Biochemistry, Virginia Tech, Blacksburg, VA 24061, USA.ORCID 0000-0002-7989-1031

Funding

The natural release of unusual peptidoglycan fragments drives persistent Lyme disease symptoms in susceptible hostsR01AI178711 · NIAID · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI Booki Min · 2023 to 2026
$2.1M
Defining the host and pathogen determinants of peptidoglycan induced pathophysiology in Lyme diseaseR01AI173256 · NIAID · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI Brandon Lyon Jutras · 2023 to 2026
$2.0M
NIAID NIH HHS R01 AI173256NIAID NIH HHS R01 AI178711
6 · The paper itself

Abstract

Lyme disease, caused by

Indexed as

Anti-Bacterial Agentsbeta-LactamsLyme DiseaseAnimalsBorrelia burgdorferiDrug Evaluation, PreclinicalHumansMiceMicrobial Sensitivity TestsAnti-Bacterial Agentsbeta-Lactams

Identifiers

PMID40267215
PMCPMC12258496

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.